Conexeu Sciences, Inc. (CNXU)
3.78
-0.11
(-2.83%)
USD |
NASDAQ |
Oct 12, 16:00
3.78
0.00 (0.00%)
After-Hours: 17:17
Conexeu Sciences Free Cash Flow (Quarterly) : -6.800M for July 31, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -6.800M |
| April 30, 2026 | -1.834M |
| January 31, 2026 |
| Date | Value |
|---|---|
| October 31, 2025 | |
| April 30, 2025 | -0.4336M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| AbbVie, Inc. | 3.114B |
| Vericel Corp. | 14.26M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |
| Alnylam Pharmaceuticals, Inc. | 292.04M |
| Anika Therapeutics, Inc. | -2.133M |